Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXPAREL IPSA Block in TKA
NCT06619340Phase 4Enrolling by invitation
- Sponsor
- Campbell Clinic Orthopaedics
- Start
- May 2024
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine in postoperative pain, sponsored by Campbell Clinic Orthopaedics. Started May 2024; status: enrolling by invitation.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06619340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06619340.